OTC · Biotechnology

Evolutionary Genomics, Inc. (FNAM) Stock

$0.00 OTC: FNAM Healthcare

Evolutionary Genomics, Inc., together with its subsidiaries, engages in the research and identification of positively selected genes in humans, animals, and commercial crops. The company develops Adapted Traits Platform, a technology platform to identify genes for enhancing crop plant traits, such as yield, sugar content, biomass, drought tolerance, and pest/disease resistance.

Valuation

MetricValue
Price$0.00
Market Cap$1331
P/E Ratio0.00
P/B Ratio0.00
P/S Ratio0.00
EPS (TTM)$-0.09
52-Week High$0.45
52-Week Low$0.00
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE100.00%
ROA-47.63%
ROCE-100.00%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity-2.00
Current Ratio3.92

Annual Financials (USD)

Metric20182019202020212022
Revenue$0$0$0$0$0
Operating Profit$-1.0M$-1.0M$-3.0M$-3.0M$-2.0M
Net Profit$-1.0M$-1.0M$-2.0M$-3.0M$-2.0M
EPS$-0.19$-0.13$-0.34$-0.52$-0.35
Op Margin-728.8%-631.5%-23038.4%——

Balance Sheet (USD)

Metric20182019202020212022
Total Assets$4.0M$4.0M$4.0M$3.0M$2.0M
Total Liabilities$4.0M$5.0M$6.0M$7.0M$4.0M
Cash$0$0$0$0$1.0M
Borrowings$0$0$2.0M$4.0M$4.0M

Cash Flow (USD)

Metric20182019202020212022
Operating Cash Flow$-1.0M$-1.0M$-2.0M$-2.0M$-1.0M
Investing Cash Flow$0$0$0$0$0
Financing Cash Flow$0$0$0$0$0
Net Cash Flow$-1.0M$0$0$0$0
Free Cash Flow$-1.0M$-1.0M$-2.0M$-2.0M$-1.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA-3.47
FCF Yield-75131.48%
Quick Ratio3.92
Interest Coverage0.00
Return 1Y—
Return 3Y—
Return 5Y—

Ownership

Insiders Held32.65%
Institutions Held0.00%
Institutions Float Held0.00%

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
CLABFCore One Labs Inc. $0.00 — -0.28 $471 0.00%
DOSEFDoseology Sciences Inc. $0.11 +0.00% -1.32 $501357 0.00%
ENZNViskase Companies, Inc. $4.71 +1.29% -0.91 $31.14M 0.00%
HLYKHealthLynked Corp. $2.70 -7.25% -2.00 $7.94M 0.00%
LIFDLFTD Partners Inc. $0.20 -2.50% -0.10 $2.89M 0.00%

About Evolutionary Genomics, Inc.

Evolutionary Genomics, Inc., together with its subsidiaries, engages in the research and identification of positively selected genes in humans, animals, and commercial crops. The company develops Adapted Traits Platform, a technology platform to identify genes for enhancing crop plant traits, such as yield, sugar content, biomass, drought tolerance, and pest/disease resistance. It serves governmental organizations, non-profit foundations, and commercial entities. The company is based in Castle Rock, Colorado.

Evolutionary Genomics, Inc. (FNAM) stock trades at $0.00 with a market capitalization of $1331. The stock is valued at a price-to-earnings (P/E) ratio of 0.00, price-to-book of 0.00, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.00 and $0.45, and currently trades 100.0% below its 52-week high.

On profitability, Evolutionary Genomics, Inc. generates a return on equity (ROE) of 100.00% — well above the market average, a sign of a high-quality business, return on capital employed of -100.00%, an operating margin of 0.00%, a net profit margin of 0.00%.

Official website: www.evolgen.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides